New treatment options for people with drug-resistant epilepsy

Between 30 and 40 percent of people with epilepsy do not respond to standard medications for controlling seizures. We spoke James Tao, MD, PhD, about treatment options for these patients with drug-resistant epilepsy.

FDA approves esketamine, drug to treat severe depression
Neuroscientist receives $2.32 million grant to study the role of the microbiome in Alzheimer’s disease